New drug duo targets Tough-to-Treat cancers in major trial
NCT ID NCT07038096
Summary
This study is testing whether a new combination of two drugs, ZG006 and ZG005, is safe and effective for people with advanced small cell lung cancer or neuroendocrine carcinoma. It will involve about 350 adult participants to see if the drug combo can shrink tumors and control the disease. The main goals are to check for side effects and measure how well the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-sen University Cancer Center
RECRUITINGGuanzhou, Guangdong, China
Contact
Conditions
Explore the condition pages connected to this study.